OBJECTIVES: It has been suggested that laparoscopic Ivor Lewis (IL) oesophagectomy reduces postoperative morbidity and mortality rates. However, data related to the long-term outcomes of this hybrid minimally invasive procedure are scarce.
INTRODUCTION
Ivor Lewis (IL) oesophagectomy is considered worldwide as a reliable and effective procedure in the surgical treatment of oesophageal cancer when the tumour is located below the carina or involves the gastro-oesophageal junction (GOJ) alone or after neoadjuvant treatment [1, 2] . Morbidity and mortality rates after IL oesophagectomy remain high despite decades of efforts in perioperative care management to reduce the surgical stress inherent in the technique [3] . Currently, the morbidity rate is 30-50% and is mainly due to respiratory complications [4] . Actual 30-day and 90-day mortality rates range between 2 and 10% depending on the volume of patients from each institution [1, 5] .
Because of the high postoperative morbidity associated with the open procedure, hybrid minimally invasive oesophagectomy (MIO) using a laparoscopic approach has been developed to reduce the surgical trauma and to decrease the respiratory consequences. The main impact of MIO techniques is the reduction of surgical stress and facilitation of the patient's access to enhanced recovery pathways, which lead to an improvement in postoperative outcomes [6] . In this setting, laparoscopy appeared to be an effective alternative to laparotomy. Hybrid MIO with laparoscopy and right thoracotomy was introduced in the last decade with promising results. Briez et al. [7] demonstrated that this technique decreased the risk of major pulmonary complications, reduced postoperative mortality rates and did not compromise the quality of the surgical resection based on simple oncological criteria such as numbers of resected lymph nodes (LNs) or the rate of R0 resections. Recently, a prospective randomized trial comparing total MIO to open procedures reported the beneficial advantages of MIO for respiratory complications with equivalent results in term of oncological results [8] . Another trial is ongoing in France (MIRO trial) but the results have not yet been published [9] .
Although the minimally invasive techniques seem to decrease the respiratory morbidity rate, the effect of such procedures on the oncological results has not yet been clearly demonstrated. Several studies have tried to assess the oncological results of MIO, but the interpretation of the results is limited due to the lack of homogeneity of the surgical techniques, the indications and the study populations [4, 10] .
The goal of this retrospective study is to assess the long-term outcomes of hybrid MIO using laparoscopy compared to laparotomy based on a propensity score matched analysis.
PATIENTS AND METHODS

Study design
The Ethics Committee of Clinical Research of the French Society of Thoracic and Cardiovascular Surgery (SFCTCV; CERC-SFCTCV-2015-3-31-17-46-5-RiPh) approved the study design. Data from all patients undergoing surgical resection for oesophageal cancer between August 2000 and December 2014 were retrospectively analysed. Data were extracted from an institutional prospective database. All of the patients who had an 'intention to treat' IL oesophagectomy were included. The patients who were converted to laparotomy were kept in the laparoscopic group. The choice of laparoscopy for the abdominal portion of the procedure was left to the surgeon's discretion. All of the other surgical procedures (i.e. left thoraco-abdominal approaches, transhiatal approaches, McKeown or Akiyama techniques and totally minimally invasive techniques) were excluded.
The patients were matched on the basis of a propensity score calculated from the logistic regression including the dependent variable (laparotomy or laparoscopy) and the independent variables: age, gender, American Society of Anaesthesiologists (ASA) score, forced expiratory volume in 1 s (FEV 1 ), surgery (first-line treatment, after neoadjuvant treatment and salvage surgery), histological type, location of the tumour and pathological stage.
In the majority of the cases, neoadjuvant treatment comprised chemotherapy only or chemotherapy with radiotherapy (45 Grays). In the case of salvage surgery, the patients were operated on after failed chemoradiotherapy (50-60 Grays). The pathological stages were estimated according to the TNM classification system published in 2009 (7th edition) [11] . The patients were seen at the outpatient clinic 1 month and 3 months postoperatively, and every 6 months thereafter; they had a systematic thoraco-abdominal computed tomography scan and regular endoscopic examinations. If recurrence was suspected, a pathological confirmation was scheduled.
First and secondary end points
The two groups were compared on the basis of standardized oncological variables according to the first and second end points of our study.
The primary end point was the assessment of the overall survival and disease-free survival (DFS) rates using Kaplan-Meier (KM) methods. Survival was measured from the date of operation and survivorship was calculated according to the KM method, including the operative mortality rate. Survival curves were assessed from the time of surgery to death from any cause or to the time of the last follow-up visit (at which time data were censored). DFS was calculated to the time of a first recurrence or death from any cause or the time of the last visit without a previous relapse. Survival and DFS curves were constructed using the KM method, and the log-rank test was used to determine significance.
The secondary end point was the assessment of the quality of surgical resection as defined by the rate of complete R0 surgical resection, the location and number of resected and positive LNs and the patterns of recurrence (loco-regional or metastatic).
Laparoscopic Ivor Lewis oesophagectomy
The patient was placed in the supine, steep reverse Trendelenburg position. Five ports were needed and CO 2 insufflation was required. The gastrohepatic ligament was divided, and the right and left crura were dissected until the GOJ was freed. Ultrasonic coagulation was used to divide the gastrocolic ligament with preservation of the right gastroepiploic arcade. The short gastric arteries were divided alongside the greater curvature to finalize mobilization of the stomach. The left gastric and celiac vessels were exposed, pulling up the stomach. Lymphadenectomy of the celiac axis was performed by transecting the left gastric vessels at their origins using a vascular stapler. An additional abdominal lymphadenectomy including the hepatic, splenic and coeliac axis was performed in case of the presence of macroscopically doubtful LNs. The surgeon systematically carried out the macroscopic preparation of the resected specimen before sending it for pathological examination in order to identify each nodal station. Hepatic, splenic and celiac LNs were grouped for analysis.
Statistical analysis
A statistical expert at our institution (A.L.) performed all of the statistical analyses using the IBM SPSS Statistics Version 20. The propensity score was performed on the variables identified above. The log-rank test was used to compare survival curves determined by the KM method. The results for continuous variables are expressed as mean ± standard deviation or median and interquartile range. Continuous variables were compared using the Student's t-test or the Mann-Whitney U-test. Categorical variables were compared using a Chi-square Pearson test or by Fisher's exact test. Comparisons of means between two groups were performed using the Student's t-test in case of symmetric distribution, otherwise the Mann-Whitney U-test was used. A Pvalue <0.05 was considered statistically significant. A multivariate analysis with logistic regression using the Cox model was used to identify risk factors for occurrence of death or recurrence. The variables used for multivariate analysis were based on the criterion of value <0.1 in univariate analysis and variables that have clinical relevance (age, ASA score, pN+/pN-, capsular rupture and R0/R1).
RESULTS
Population
Over a 12-year period, 379 oesophagectomies (mean 31.5 procedures/year) for cancer were performed in our department. Among them, 272 oesophagectomies were performed using the IL technique: 179 with laparotomy and 93 with laparoscopy (Table 1) . Two homogeneous groups of 70 patients each (laparotomy and laparoscopy groups) were obtained from a propensity score including eight independent variables. The demographic, clinical and histological characteristics of both groups are summarized in Table 2 . From 2002 to 2008, the laparoscopy and laparotomy groups included 39 and 38 patients, respectively. From 2009 to 2014, the laparoscopy and laparotomy groups included 31 and 32 patients, respectively. Two patients in the laparoscopic group were converted to laparotomy because of bleeding. The 30-day mortality rate was 5% (seven patients: four in the laparoscopic group and three in the laparotomy group). The 90-day mortality rate was 8.6% (12 patients: six in each group).
Survival and disease-free survival
The median follow-up period for patients without recurrence was 32 months (range 1-104). At the end of the follow-up period, 33 patients (24%) had died. The 5-year overall survival rate of the entire cohort (n = 140) was 69%. The 5-year overall survival rates in the laparoscopy and laparotomy groups were 65% and 73%, respectively (P = 0.891) (Fig. 1) . The median survival rate was not reached in either group. The 5-year DFS rate of the total cohort was 49%. The 5-year DFS rate in the laparoscopy and laparotomy groups was 48% and 51%, respectively (P = 0.912) (Fig. 2) .
Lymph node dissection and complete resection
The results of LN dissection are detailed in Table 3 . The total number of resected LNs was 22 ± 11 (9 ± 6 abdominal LNs and 13 ± 8 mediastinal LNs) in the laparotomy group and 22 ± 10 (8 ± 5 abdominal LNs 14 ± 8 mediastinal LNs) in the laparoscopic group (P = 0.902). The rates of complete surgical resection by laparotomy and laparoscopy were 93% and 97%, respectively (P = 0.441). No patient had an R2 resection. Five patients in the laparotomy group had an R1 resection: invasion of the gastric distal resection margin (n = 2), tumour infiltration of the mediastinal fat (n = 1) and tumour invasion of the proximal resection margin (n = 2). Two patients in the laparoscopic group had an R1 resection: invasion of the gastric distal resection margin (n = 2).
Recurrence
Thirty-two patients had tumour recurrence during the follow-up period (Table 4) . Eight patients (6%) had an isolated loco-regional recurrence (Table 5) : gastro-oesophageal anastomosis (n = 2) and mediastinal or abdominal positive LNs (n = 6). The loco-regional recurrence rate of the laparoscopy and laparotomy groups was 7% and 4%, respectively (P = 0.719). Twenty-four patients had metastatic recurrence: liver, lung, pleural, peritoneal, brain, bone and skin. The recurrence rates of the metastatic laparotomy and laparoscopic groups were 16% and 19%, respectively (P = 0.826).
Multivariate analyses
On multivariate analysis of risk factors affecting survival, no variable reached the level of significance (Table 6 ). On multivariate analysis of risk factors affecting DFS, the only significant variable was extracapsular LN invasion (Table 6 ). 
DISCUSSION
Over the two last decades, the numbers of minimally invasive procedures performed by thoracic surgeons have increased worldwide. Although the feasibility of these techniques has been suggested for all types of major resections in thoracic cancer surgery, there are few reports on efficacy and relevance to longterm outcomes. Several trials are ongoing in mediastinal and in lung cancer with video-assisted thoracic surgery or roboticassisted thoracic surgery [12] . In oesophageal cancer, because of the complexity of the surgical procedure in the chest and in the abdomen, several minimally invasive techniques have been described. Oesophagectomy can be performed using a 'hybrid' procedure: a combination of open techniques with laparoscopy or thoracoscopy (hybrid MIO). Oesophagectomy can also be performed using laparoscopy and thoracoscopy (total MIO). The randomized trial of Biere et al. [8] has demonstrated the advantage of total MIO compared to the open approach during the postoperative period. The first end point of the study was to measure the impact of the total MIO on respiratory complications. Sixteen (29%) patients in the open oesophagectomy group had significantly more pulmonary infection in the first 2 weeks compared with five (9%) in the minimally invasive group. The results were similar for pulmonary infection acquired in-hospital (34% vs 12%). Briez et al. also suggested the impact on respiratory complications from the results of a prospective, non-randomized trial; they observed that hybrid MIO using laparoscopy compared with laparotomy resulted in fewer major postoperative pulmonary complications and a lower inhospital mortality rate. On the basis of this, the authors conducted a prospective randomized trial (MIRO trial) comparing laparotomy and laparoscopy. To date, the study has completed patient accrual, but the final results of the trial have not yet been published [9] .
On the basis of the available literature, it seems reasonable to conclude that the use of hybrid MIO using laparoscopy would result in a significant reduction of respiratory complications after oesophagectomy. The real impact of laparoscopy compared to thoracoscopy is not clear, and the available data are insufficient to confirm which part of the oesophagectomy would benefit from minimally invasive techniques. Regardless of the MIO technique used, some robust arguments indicate that this surgical process would significantly decrease the incidence of postoperative respiratory complications. The decrease in complications would have a potentially positive impact on survival and on timing of tumour recurrence after oesophagectomy [13] .
Though the beneficial effect of minimally invasive techniques on reducing respiratory morbidity is generally accepted, the effects of such procedures on oncological results are not well established. Several studies have tackled this question, but the interpretation of the results remains limited due to the lack of homogeneity of surgical techniques, indications and study populations [4, 10] . Results from this study, which is based on data from a homogeneous population during a recent period, suggest that laparoscopy would not compromise oncological results compared to an open technique. The 5-year DFS rate in our series is comparable to that from the study of du Rieu et al. [14] (49% vs 51%). However, the 5-year overall survival rate in our series is higher than that of du Rieu et al. [14] (69% vs 49%). Our results suggest similar 5-year overall survival rates in the two groups. Our data are in line with those from the meta-analysis of Dantoc et al. [15] . Rates of R0 resection in the laparoscopy and laparotomy groups in our study were similar. The R0 resection rates of the laparoscopy and laparotomy groups were also comparable in the study of Briez et al. [7] (87.9% and 85.7%, respectively). The tumour recurrence rates (loco-regional or metastatic) in our series (23%) are lower than those of du Rieu et al. (44%) or Lou et al. (38%) [14, 16] . These differences can be explained by a shorter follow-up period in our study. The total numbers of LNs resected by laparotomy and laparoscopy were similar in our study. The meta-analysis of Dantoc et al. [15] found a higher number of resected LNs when minimally invasive techniques were used. Criticisms of MIO with regard to the small numbers of resected LNs are probably valid in centres starting a MIO program; they will encounter significant differences in surgical performances due to the steep learning curve. However, in experienced centres, it seems reasonable to conclude that an extended lymphadenectomy can safely be performed with MIO techniques, although there is an imbalance between Eastern and Western countries. For example, in Japan, data from Japanese series, where MIO is widely accepted, indicated more LNs resected than in Western countries. We acknowledge that the number of LNs resected at the level of the celiac axis was lower in our laparoscopy group. This difference is likely due to our technique, whereby the left gastric and celiac LNs are resected after division of the left gastric vessels using an automatic stapler. Careful dissection of the celiac axis before transection of the left gastric vessels would be a more accurate way to increase the number of LNs. Again, we acknowledge that this study was not powered enough to assess the extent of LN dissection. We cannot make any conclusion about the celiac axis clearance due to the inherent limitation of the retrospective design of the study.
Despite its homogeneous population and its comparative design based on a propensity score, our study has several limitations. First, the study in its current form is a retrospective comparison of two cohorts. A randomized design would have been more relevant. However, this limitation should be viewed in relation to the rigorous propensity matched score over nine variables. Second, we have voluntarily chosen to include pTNM as part of the propensity score variable. We agree that cTNM would have been more reliable from a statistical point of view but not from a clinical point of view. Several factors can explain our choice. During the study period (2002-2014), oesophageal cancer staging was not similar between patients. High-frequency endoscopic ultrasonograms and positron emission tomographycomputed tomography scans have been used in our department only since 2008. Moreover, during the same period, the TNM classification system changed three times (5th, 6th and 7th TNM editions). At least, the pTNM as defined in the latest 7th TNM classification permits a reliable pairwise comparison between patients, taking into account neoadjuvant therapy as well as other variables in the propensity score. Third, we did not make a distinction between the Siewert I or II classification for the GOJ tumour, leading to potential selection bias. Starting in 2002, our MIO program with laparoscopy was influenced by the learning curve effect, thereby explaining the difference observed in the number of resected LNs at the level of the celiac axis.
CONCLUSION
Laparoscopy does not compromise long-term oncological results of hybrid MIO compared to a conventional approach. The 5-year overall survival and DFS rates after open and hybrid MIO are similar. The quality of the operations also seems equivalent in the two techniques. The R0 resection rate and the total number of resected LNs in the laparotomy and laparoscopy groups were similar in our study, with the exception of the number of celiac LNs, which was lower in the laparoscopy group. Randomized controlled trials are needed to assess the long-term results of open surgery and laparoscopy.
